A selective, nonpeptide CCR1 antagonist that can displace the endogenous CCR1 ligands, MIP-1α, RANTES, and MCP-3 with Ki values of 1, 2.8, and 5.5 nM, respectively; reduces chemotaxis of inflammatory cells in models of multiple sclerosis, sepsis, rheumatoid arthritis, and lupus nephritis.